Journal of Clinical Investigation , 71 (6), 1554
There was also a reduced risk of moderate exacerbation [6]
J Biol Chem 247(13):42484252 Kirabo A, Fontana V, de Faria APC, Loperena R, Galindo CL, Wu J, Bikineyeva AT, Dikalov S, Xiao L, Chen W, Saleh MA, Trott DW, Itani HA, Vinh A, Amarnath V, Amarnath K, Guzik TJ, Bernstein KE, Shen XZ, Shyr Y, Chen S, Mernaugh RL, Laffer CL, Elijovich F, Davies SS, Moreno H, Madhur MS, Roberts J, Harrison DG (2014) DC isoketal-modified proteins activate T cells and promote hypertension
Always consult a healthcare professional before making changes to medication or diet
A phase II clinical trial in PD showed dose-dependent efficacy, with the best effect being a 44% slowing of the Unified Parkinsons Disease Rating Scale (Shults et al
Growth-hormone-axis peptides such as tesamorelin and CJC-1295 are typically considered as one element of a broader, individualized plan rather than on their own